These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12607587)

  • 1. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.
    van Venrooij WJ; Hazes JM; Visser H
    Neth J Med; 2002 Nov; 60(10):383-8. PubMed ID: 12607587
    [No Abstract]   [Full Text] [Related]  

  • 2. Are prognostic factors in rheumatoid arthritis of any use in daily clinical practice?
    van Riel P
    Neth J Med; 2002 Nov; 60(10):381-2. PubMed ID: 12607586
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New diagnostic tests for rheumatoid arthritis].
    Hayashi N; Kumagai S
    Rinsho Byori; 2003 Oct; 51(10):1030-5. PubMed ID: 14653204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New biomarkers for rheumatoid arthritis].
    Hayashi N; Nishimura K; Kumagai S
    Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deiminated viral peptide to detect antibodies in rheumatoid arthritis.
    Merlini G; Anzilotti C; Chimenti D; Tommasi C; Bombardieri S; Migliorini P
    Ann N Y Acad Sci; 2005 Jun; 1050():243-9. PubMed ID: 16014539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antifilaggrin antibody as a serological marker for the diagnosis of rheumatoid arthritis].
    Nakazono K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():351-4. PubMed ID: 15799376
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 14. Very early 'Rheumatoid' arthritis cohorts: limited by selection.
    Inanc M
    Rheumatology (Oxford); 2007 Feb; 46(2):185-7. PubMed ID: 17043049
    [No Abstract]   [Full Text] [Related]  

  • 15. [The new serological markers of rheumatoid arthritis].
    Tuchocka-Piotrowska A; Puszczewicz M
    Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
    Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
    [No Abstract]   [Full Text] [Related]  

  • 18. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies as predictors of biological therapy for early rheumatoid arthritis].
    da Mota LM; dos Santos Neto LL; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Acta Reumatol Port; 2010; 35(2):156-66. PubMed ID: 20711091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
    Tant L; Steinfeld S
    Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.